🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.Eisai US and Biogen announced top-line results from the Phase III #clinicaltrial Clarity AD of #lecanemab in early #Alzheimer’s disease. Primary endpoint and all key secondary endpoints were met. We look forward to hearing more at #CTAD22 alzheimer-europe.org/news/eisai-and…

The fourth RADAR-AD consortium meeting took place as a hybrid event on the 28th and 29th of September in Amsterdam, The Netherlands. Read more about the discussions, patient involvement talk and keynote speakers here: radar-ad.org/newsroom/radar… @IHI Alzheimer Europe Neuronet

RADAR-AD researcher Ioulietta Lazarou from the ΕΚΕΤΑ-CERTH spoke at the 32nd Alzheimer Europe conference “Building bridges” (#32AEC). She presented the reserach and experiences of RADAR-AD's smart home study. Read on here: radar-ad.org/newsroom/radar…

Last month RADAR-AD was represented at the European Digital Medicine Conference. Prof. Dr. Holger Fröhlich (Fraunhofer SCAI), Group leader AI & data science and deputy head of bioinformatics, spoke about RADAR-AD's functional domains and modelling work:radar-ad.org/newsroom/radar…

On the 30 Nov, RADAR-AD's participating clinical center in Geneva (Switzerland) included the 220th and final participant in the RADAR-AD study. This represents a significant milestone for the RADAR-AD clinical trial: lnkd.in/eZtUVEwJ Centre for Healthy Brain Ageing, KCL Alzheimercentrum Amsterdam (inactief) King's College London

Last week Prof. Dr. Holger Fröhlich (Fraunhofer SCAI), leading RADAR-AD’s work stream on functional domains and modelling, gave a talk on the project at the Luxembourg Centre for Systems Biomedicine. Find out more about this presentation here: radar-ad.org/newsroom/radar…

Last week, Chris Roberts., member of the RADAR-AD Patient Advisory Board, shared his experience of patient involvement in dementia research at the EFPIA workshop “Enhancing #patientcentric outcome measures and clinical trials with Digital Health Technologies”:radar-ad.org/newsroom/chris…

Happy new year from the RADAR-AD team! Check out our latest newsletter featuring updates from the RADAR-AD project and plans for the last 6 months of activities: radar-ad.org/newsroom/welco… Neuronet Alzheimer Europe Ageing Research KCL Innovative Health Initiative

Registrations are now open! Reserve your spot at the upcoming 2nd RADAR-base Symposium taking place in Utrecht, Netherlands. ✏️ Sign up here: bit.ly/rb-symposium-2… RADAR-base.org RADAR-AD PHIDL Innovative Health Initiative #radarbase #wearables #opensource #conference #Utrecht

IMI projects RADAR-AD, RADAR-CNS, IDEA-FAST-Project Mobilise-D are showing how smartphones and wearable devices can help understand how patients with different brain diseases experience their conditions in their everyday lives. #BAW2023 #BrainAwarenessWeek

On the 14th of March, RADAR-AD investigators finalized the data set of the main study with data collected from 232 study participants. During the 8-week data collection period, researchers measured participants’ functioning in daily life. More: radar-ad.org/newsroom/radar… Innovative Health Initiative

🚨 Register for the RADAR-base.org Symposium 2023 for free! bit.ly/rb-symposium-2… This second edition of the RADAR-base Symposium is dedicated to exploring the latest developments in the field of Mobile Health #symposium #wearables Innovative Health Initiative RADAR-AD

Join RADAR-AD's public event on the 16th May in Amsterdam in which we will explain our work, showcase the results from our studies and discuss plans for the exploitation and sustainability of our achievements! Explore the program, speakers and our research radar-ad.org/newsroom/radar…

The RADAR-AD consortium celebrates 4 years of research and achievements in a close-out project meeting and a public event that took place in Amsterdam, on the 15th and 16th of May: radar-ad.org/newsroom/radar… Alzheimer Europe Innovative Health Initiative Ageing Research KCL Centre for Healthy Brain Ageing, KCL

A recent RADAR-AD study investigated the effect of meditation practices on the human brain across the #Alzheimer spectrum by using a novel portable #EEG headband in a #smarthome environment. Find out more: radar-ad.org/newsroom/elici… ΕΚΕΤΑ-CERTH

On the 5th of June, the RADAR-AD consortium met with the European Medicines Agency (EU Medicines Agency) to seek qualification advice on its research and use of #digital devices for future studies concerning medicine development. Find out more here: radar-ad.org/newsroom/radar…

RADAR-AD paper investigates the value of #RMTs in the assessment of #neurodegenerative conditions, their usability and feasibility and the learnings from the project’s #public involvement and #regulatory interactions: radar-ad.org/newsroom/new-c… Alzheimer Europe Innovative Health Initiative Centre for Healthy Brain Ageing, KCL

On June 9th, the Alzheimer center at Amsterdam UMC held a participant day for RADAR-AD study participants. RADAR-AD researchers discussed developments in #Alzheimer’s research and presented RADAR-AD results: radar-ad.org/newsroom/alzhe… Ageing Research KCL Alzheimer Europe Innovative Health Initiative

A recent RADAR-AD consortium publication sheds light on the #ethical challenges of using remote monitoring technologies (#RMTs) for #clinical research. Find out more here: radar-ad.org/newsroom/radar… Alzheimer Europe Innovative Health Initiative Centre for Healthy Brain Ageing, KCL King's College London Amsterdam UMC JNJInnovative Medicine

What is the potential of #digital technologies to improve the assessment of #Alzheimer’s disease?RADAR-AD videos provide the answer and expain its research, preliminary results and patient experiences with the project: radar-ad.org/newsroom/radar… Innovative Health Initiative Alzheimer Europe Centre for Healthy Brain Ageing, KCL